✦ LIBER ✦

Barrett’s esophagus: Is dysplasia a reliable marker in surveillance after endoscopic treatment?

✍ Scribed by Maria-Anna Ortner

Book ID: 107537858
Publisher: Springer
Year: 2001
Tongue: English
Weight: 178 KB
Volume: 3
Category: Article
ISSN: 1522-8037
DOI: 10.1007/s11894-001-0075-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DNA/protein flow cytometry as a predicti

DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: Thirteen-year follow-up study on a cohort of patients

✍ Laura Teodori; Wolfgang Göhde; Massimo Persiani; Fabio Ferrario; Donatella Tirin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

Intestinal metaplasia identifies Barrett's esophagus (BE) and is associated with an increased risk for esophageal adenocarcinoma. Dysplasia occurs as an intermediate step. However, progression from metaplasia to neoplasia without the demonstration of dysplasia has been described. The role of dual-pa

Acquired prolactin deficiency (APD) afte

Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status

✍ A. Mukherjee; R. D. Murray; G. M. Teasdale; S. M. Shalet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Endoscopic cap resection for treatment o

Endoscopic cap resection for treatment of early Barrett's neoplasia is safe: a prospective analysis of acute and early complications in 216 procedures

✍ F. P. Peters; K. P. M. Brakenhoff; W. L. Curvers; W. D. Rosmolen; F. J. W. Ten K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB